O transtorno glutamatérgico na esquizofrenia / Glutamatergic disorder in schizophrenia
Rev. méd. Minas Gerais
;
7(1): 23-27, jan.-mar. 1997. tab
Article
in Portuguese
| LILACS
| ID: lil-755246
RESUMO
A excitoxicidade relacionada ao neurotransmissor aminoácido glu- ta mato e ao seu receptor NMDA (n-metil-d-aspartato) consiste em um mecanismo de elevado potencial para explicar a fisiopatologia da esquizofrenia. Os neurolépticos atípicos clozapina e olanzapia têm potencial para proteger contra a neurotoxicidade gerada pelos antagonistas de NMDA.
ABSTRACT
Excitotocicity due to glutamate and its NMDA (N-methyl-D- aspartate) receptor are a possible mechanism for the physiopatholoy of schizophrenia. The atipical neuroleptic drugs clozapine and olanzapina present the potencial to protect against neu- rorocity caused by NMDA antagonists.
Search on Google
Index:
LILACS (Americas)
Main subject:
Schizophrenia
/
Receptors, N-Methyl-D-Aspartate
/
Glutamic Acid
Limits:
Humans
Language:
Portuguese
Journal:
Rev. méd. Minas Gerais
Journal subject:
Medicine
Year:
1997
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade Federal de Minas Gerais/BR
Similar
MEDLINE
...
LILACS
LIS